Prospective, Randomized, Multi-center, Open Label, Phase III Study to Evaluate the Efficacy and Safety of Immunosuppression Following a Heart-beating Cadaveric Renal Transplantation Based on the Use of Rabbit Anti-T-lymphocyte Serum, Tacrolimus and Mycophenolate, Free of Concomitant Corticosteroids From the Start of Immunosuppression
Latest Information Update: 03 Aug 2022
At a glance
- Drugs Antithymocyte globulin (Primary) ; Corticosteroids; Mycophenolate mofetil; Mycophenolate sodium; Tacrolimus
- Indications Transplant rejection
- Focus Therapeutic Use
- Acronyms IBERICA
- 31 Jul 2022 This trial has been completed in Spain (End Date: 29 Apr 2010), according to European Clinical Trials Database record.
- 04 Apr 2011 New trial record